Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Graco Inc. has appointed Richard B. Lewis to its Board of Directors and Audit Committee, effective December 3, 2026. Mr. Lewis currently serves as the President and CEO of Donaldson Company, Inc. and will receive Graco's standard non-employee director compensation.
Edward M. Weil, Jr. resigned from the board of directors of National Healthcare Properties, Inc. effective September 11, 2026. The company stated that his departure was not due to any disagreement regarding operations, policies, or practices.
NPK International Inc. appointed James Barton as Executive Vice President, Commercial Growth & Operations, effective September 22, 2026. He succeeds Lori Briggs, who will depart from her role as Executive Vice President, Business Operations on September 14, 2026. Barton joins from Clear Water Services and brings over 20 years of experience in strategic sales and operations.
Q32 Bio appointed José Trevejo, M.D., Ph.D., as Chief Medical Officer and Ellie Hershberger, Pharm.D., as Chief Development Officer. Both executives bring extensive experience in late-stage clinical development and regulatory strategy as the company prepares to advance bempikibart into a registration-directed program for alopecia areata in 2027.
Flowserve Corporation announced that Amy B. Schwetz will resign as CFO on September 30, 2026, to join another public company. Brian Ezzell, currently VP of FP&A, Treasurer, and Investor Relations, has been appointed as the new Senior Vice President and CFO effective October 1, 2026. Ezzell will receive a base salary of $625,000 and a target annual long-term incentive award of $1.6 million starting in 2027.
State Street Corporation announced two executive leadership appointments effective immediately: Mostapha Tahiri as President of State Street Alpha and Ann Fogarty as Enterprise Chief Operating Officer. Ms. Fogarty, who previously served as Investment Services COO, will have a target incentive compensation award of $5.65 million in her new role.
Deniece Ky resigned as the Company’s Principal Accounting Officer and Senior Financial Director, effective September 17, 2026. The resignation was for personal reasons and includes a lump sum payment of $42,755.89 for accrued but unused paid time off.
David Enholm has resigned as Chief Financial Officer of Zone Frontier Inc., effective September 11, 2026, in connection with his retirement. The company stated the departure was not due to any disagreement regarding operations, policies, or practices.
Flexsteel Industries appointed Anand S. Kangala to its Board of Directors as a Class I director and member of the Audit and Ethics Committee, effective September 10, 2026. Mr. Kangala, currently the Chief Digital and Technology Officer of Trex Company, brings expertise in digital transformation, AI, and enterprise technology modernization to the board. He will receive an annual retainer of $75,000 plus quarterly stock grants valued at $26,250.
Thomas A. Fitzgerald resigned as CFO and Director of TransCode Therapeutics effective September 9, 2026. The company entered into a separation agreement providing for up to $1.25 million in severance payments, accelerated vesting of existing equity, and a new grant of 185,000 stock options. A portion of the cash severance and option vesting is contingent on the company achieving specific funding thresholds of $5 million and $10 million.
Jeff Mason, the Chief Operating Officer of Flux Power Holdings, Inc., tendered his resignation effective September 25, 2026. In connection with his departure, the company entered into a separation agreement providing Mr. Mason with a $5,000 payment subject to a general release of claims.
Lisa Fan resigned as CEO and Director of Fly-E Group, Inc., effective immediately, with no reported disagreements. The Board appointed Qiang Chen as the new CEO and Jingxia Song as an independent Director and committee member to fill the vacancies.
Dr. Duane Nash resigned from the Board of Directors of Immunic, Inc. on September 10, 2026. Following the resignation, the company reduced the size of its Board from ten to nine members.